Sun Pharma Advanced Research Company's Stock Faces Decline, Labeled as 'Strong Sell' by MarketsMOJO

Sun Pharma Advanced Research Company (SPARC) has recently faced a decline in its stock price, with a loss of -5.09% on November 4th, 2024. This decline has been reflected in the stock call given by MarketsMOJO, which has labeled it as a 'Strong Sell'. The company's performance today has underperformed the sector by -2.47%, with the stock touching an intraday low of Rs 207.2 (-4.14%). Additionally, SPARC is currently trading lower than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. In comparison to the overall market performance, Sun Pharma Advanced Research Company has also shown a decline. Its 1 day performance is -5.14% compared to the Sensex's -1.19%, and its 1 month performance is -2.91% compared to the Sensex's -3.57%. Despite these recent declines, Sun Pharma Advanced Research Company remains a midcap company in the pharmaceuticals and drugs industry. As a midcap company, it falls in the middle range in terms of size and market capitalization. Investors and experts have not been mentioned in this article, as it aims to provide a neutral and informative tone without any future potential or recommendations. These facts and figures serve as a snapshot of the current state of Sun Pharma Advanced Research Company's stock performance.